Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: Possible implications for targeted therapy

• Main Authors: Teng, Y.H.-F, Tan, W.-J, Thike, A.-A, Cheok, P.-Y, Tse, G.M.-K, Wong, N.-S, Yip, G.W.-C, Bay, B.-H, Tan, P.-H
• Other Authors: ANATOMY
• Format: Article
• Published: 2020
• Subjects: epidermal growth factor receptor; paraffin; DNA; epidermal growth factor receptor 2; estrogen receptor; progesterone receptor; adult; aged; article; breast cancer; chromosome inversion; codon; DNA extraction; exon; gene deletion; gene mutation; histopathology; human; human tissue; immunohistochemistry; major clinical study; missense mutation; mutational analysis; polymerase chain reaction; protein expression; sequence analysis; biosynthesis; breast tumor; cohort analysis; female; genetics; metabolism; middle aged; molecularly targeted therapy; mutation; nucleotide sequence; proto oncogene; Adult; Aged; Breast Neoplasms; Cohort Studies; DNA Mutational Analysis; DNA, Neoplasm; Female; Genes, erbB-1; Humans; Middle Aged; Molecular Targeted Therapy; Mutation; Receptor, Epidermal Growth Factor; Receptor, erbB-2; Receptors, Estrogen; Receptors, Progesterone
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183258
• Institution: National University of Singapore

10.1186/bcr2857